Lintuzumab
Based on 1 Customer Validation
Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.09%
- CAS 番号: 166089-32-3
- 分子量:145.24 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Radionuclide-Drug Conjugates (RDCs) アイソフォーム固有の製品をすべて表示
More
生物活性
Human IgG1 kappa
Human
|
Siglec-3/CD33 |
RDC Antibody |
Lintuzumab (5 μg/mL, 0.1-2 h) induces phosphorylation of CD33 and recruitment of Shp-1 phosphatase inHL60 cells[2].
Lintuzumab (2500 ng/mL) significantly decreases the production of tumorigenic growth factors including IL-8, MCP-1, IP-10 and RANTES in KG-1 cells[2].
Lintuzumab (0.1 ng/mL-10 μg/mL) exerts multiple effector functions including the ability to mediate ADCC and ADCP in AML cell lines[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
-
Immobilized Siglec-3/CD33 Protein, Human can bind Lintuzumab. The EC50 for this effect is 1.206 ng/mL. -
Flow cytometric analysis of 1.5X106 THP-1 cells with Lintuzumab (HY-P9983, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 (S228P) kappa, Isotype Control (HY-P99003, blue) was used as the isotype control.
化学情報
-
CAS 番号 166089-32-3
-
性状 Liquid
-
分子量 145.24 kDa
-
Color Colorless to light yellow
-
SMILES
[Lintuzumab]
-
別名
SGN-33; HuM-195; GLK-33 Antibody
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)